A person shielded by melatonin from chemotherapy.

Can Melatonin Protect Against Chemotherapy's Harsh Side Effects?

Author's portrait.
Theo Raines in Health & Wellness August 2025 • 4 min read.

"Discover how this natural hormone could offer a shield against DNA damage from cancer treatments, potentially improving patient outcomes and quality of life."


Chemotherapy is a powerful tool in the fight against cancer, but it often comes with a host of unwelcome side effects. These arise because chemotherapy drugs, while targeting cancer cells, can also harm healthy cells in the body. One area of particular concern is DNA damage, which can lead to long-term health issues and reduced quality of life for patients. Imagine being able to lessen these harmful effects, making cancer treatment more bearable and effective.

Melatonin, a hormone primarily produced by the pineal gland, is well-known for its role in regulating sleep. However, emerging research suggests that melatonin possesses potent antioxidant and DNA-protective properties. Studies are now investigating whether melatonin can mitigate the DNA damage induced by chemotherapy, offering a potential lifeline for cancer patients undergoing treatment.

This article delves into the groundbreaking research exploring melatonin's ability to safeguard against the damaging effects of chemotherapy drugs, specifically focusing on a study that examines its impact on DNA integrity in rats. We will explore how melatonin supplementation could potentially revolutionize cancer treatment support, offering a beacon of hope for minimizing side effects and improving overall patient outcomes.

How Does Melatonin Shield DNA During Chemotherapy?

A person shielded by melatonin from chemotherapy.

A recent study published in the Brazilian Journal of Medical and Biological Research investigated the protective effects of melatonin against DNA damage induced by cyclophosphamide (CP), a commonly used chemotherapy drug. The research, conducted on rats, provides compelling evidence of melatonin's potential to act as a buffer against the harsh side effects of cancer treatment.

The study involved administering cyclophosphamide to rats to mimic the DNA-damaging effects of chemotherapy. Some of the rats were also given melatonin supplements. Researchers then analyzed bone marrow cells to assess the extent of chromosomal aberrations and DNA damage. The results revealed a striking difference between the groups:

  • Reduced Chromosomal Aberrations: Rats treated with melatonin alongside cyclophosphamide exhibited significantly fewer chromosomal aberrations compared to those that received cyclophosphamide alone.
  • Protection Against Oxidative Lesions: Melatonin was shown to protect against oxidative lesions, a type of DNA damage, both 24 and 48 hours after cyclophosphamide administration.
  • Enhanced DNA Repair: Melatonin upregulated the expression of Xpf mRNA, a key component in the DNA nucleotide excision repair machinery, indicating that it promotes DNA repair processes.
These findings suggest that melatonin can effectively protect bone marrow cells from CP-induced chromosome aberrations, potentially offering a valuable strategy for minimizing DNA damage during chemotherapy. By bolstering the body's natural defense and repair mechanisms, melatonin could pave the way for more tolerable and effective cancer treatments.

The Future of Melatonin in Cancer Care

The research on melatonin and its protective effects against chemotherapy-induced DNA damage is still evolving, but the initial findings are promising. Melatonin's ability to minimize chromosomal aberrations, protect against oxidative lesions, and enhance DNA repair mechanisms suggests it could be a valuable addition to cancer treatment regimens. As research continues, we may see melatonin playing an increasingly important role in improving the quality of life and treatment outcomes for cancer patients worldwide.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is melatonin, and what role might it play in cancer treatment?

Melatonin is a hormone primarily produced by the pineal gland that is known for regulating sleep cycles. However, research indicates it also has potent antioxidant and DNA-protective properties. This means it can potentially shield healthy cells from damage, particularly during treatments like chemotherapy.

2

Why is DNA damage a concern during chemotherapy, and how could melatonin help?

Chemotherapy drugs like cyclophosphamide are designed to target cancer cells, but they can also harm healthy cells, leading to DNA damage and other side effects. Minimizing this damage is crucial for improving the quality of life for cancer patients and preventing long-term health issues. Melatonin may help reduce this DNA damage.

3

How does melatonin protect against DNA damage, according to the research?

Research has demonstrated that melatonin can minimize chromosomal aberrations, protect against oxidative lesions, and enhance DNA repair mechanisms. Specifically, studies have shown that melatonin upregulates the expression of Xpf mRNA, a key component in the DNA nucleotide excision repair machinery. By bolstering the body's natural defense and repair mechanisms it can minimize DNA damage.

4

What is cyclophosphamide, and how is it related to research on melatonin and DNA damage?

Cyclophosphamide (CP) is a chemotherapy drug that can induce DNA damage. Studies have used CP to mimic the effects of chemotherapy in research settings, such as a recent study on rats. Melatonin was administered alongside cyclophosphamide and demonstrated the ability to protect against the DNA damaging effects of CP.

5

What does the future hold for melatonin in cancer care?

Melatonin's role in cancer care is still being researched, but initial findings suggest it could be a valuable addition to treatment regimens. Its ability to minimize chromosomal aberrations, protect against oxidative lesions, and enhance DNA repair mechanisms indicates that melatonin could improve the quality of life and treatment outcomes for cancer patients. Further research is needed to fully understand its potential and optimal usage.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.